Seasoned biopharmaceutical executive with over 30 years of drug development experience New Haven, Conn., February 18, 2020 – Trevi Therapeutics, Inc.
Driven by aging infrastructure, US utilities are making significant investments to replace and upgrade as well as expand new and
Acquisition adds production capacity, engineering support, product breadth, and operations leadership expertise to existing capabilities Nashville, TN, January 9, 2020
COLUMBUS, IN (December 9, 2019) – Grammer Industries, Inc., (“Grammer” or the “Company”) an Indiana-based hazardous materials transportation and logistics
NEW HAVEN, Conn., Nov. 13, 2019 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on
New York and London, October 25, 2019 –Stellex Capital Management (“Stellex”), a middle market private equity firm with offices in
